Biltmore Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$410K Buy
341
+14
+4% +$14.3K 0.13% 46
2026
Q1
$301K Buy
327
+8
+3% +$8.11K 0.11% 51
2025
Q4
$342K Sell
319
-11
-3% -$10.5K 0.13% 50
2025
Q3
$252K Buy
330
+17
+5% +$12.7K 0.1% 55
2025
Q2
$244K Buy
313
+1
+0.3% +$777 0.1% 55
2025
Q1
$258K Hold
312
0.11% 54
2024
Q4
$241K Buy
312
+66
+27% +$54.6K 0.1% 53
2024
Q3
$218K Buy
246
+5
+2% +$4.5K 0.09% 54
2024
Q2
$218K Buy
+241
New +$193K 0.09% 51
2016
Q1
Sell
-2,954
Closed -$249K 38
2015
Q4
$249K Sell
2,954
-176
-6% -$14.6K 0.22% 34
2015
Q3
$262K Buy
3,130
+26
+0.8% +$2.19K 0.23% 33
2015
Q2
$259K Buy
3,104
+60
+2% +$4.57K 0.22% 38
2015
Q1
$221K Hold
3,044
0.19% 38
2014
Q4
$210K Buy
+3,044
New +$205K 0.18% 36

Other funds holding LLY

Biltmore Wealth Management's LLY Position: Q2 2026 in Review

Biltmore Wealth Management increased its Eli Lilly (LLY) stake by 4.3% in Q2 2026, buying an estimated $14.3K and bringing the position to 341 shares worth $410K. The position accounts for 0.13% of the portfolio, ranked #46.

Biltmore Wealth Management first reported a position in LLY in Q4 2014 and has held it in 14 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Biltmore Wealth Management held 341 shares of Eli Lilly worth $410K as of Q2 2026.
  • Biltmore Wealth Management bought 14 Eli Lilly shares in Q2 2026, an estimated $14.3K.
  • Eli Lilly made up 0.13% of Biltmore Wealth Management's portfolio in Q2 2026, its #46 holding.
  • Biltmore Wealth Management first reported a position in Eli Lilly in Q4 2014 and has held it in 14 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Biltmore Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.